FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

385114002: Prolonged-release transdermal patch (dose form)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
1459292019 Transdermal patch (product) en Fully specified name Inactive Only initial character case insensitive SNOMED CT core module
1479376011 Transdermal patch en Synonym Inactive Entire term case insensitive SNOMED CT core module
2621574015 Patch en Synonym Inactive Entire term case insensitive SNOMED CT core module
2660372013 Transdermal patch (qualifier value) en Fully specified name Inactive Entire term case insensitive SNOMED CT core module
3634738017 Prolonged-release transdermal patch (dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3634739013 Prolonged-release transdermal patch en Synonym Active Entire term case insensitive SNOMED CT core module
106069801000001110 Transdermal patch en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom Edition module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Prolonged-release transdermal patch Is a Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Is a Drug patch false Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form intended site Transdermal true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Is a Transdermal dose form true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form administration method Apply true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form transformation No transformation true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form release characteristic Prolonged-release true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has basic dose form Patch true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Capsaicin 179mg/hour transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely buprenorphine 20 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely buprenorphine 10 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 5microgram/hour transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicotine 11mg/24hours patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicotine 22mg/day patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely glyceryl trinitrate 800 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely glyceryl trinitrate 200 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely glyceryl trinitrate 400 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely glyceryl trinitrate 600 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 0.025mg/day patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 0.0375mg/day patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 0.05mg/day patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 0.075mg/day patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 0.1mg/day patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Scopolamine 0.5mg/24 hr patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely glyceryl trinitrate 300 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 0.05mg/norethindrone acetate 0.14mg/day transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 0.05mg/norethindrone acetate 0.25mg/day transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 14mcg/day transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Ethinyl estradiol 0.02mg / norelgestromin 0.15mg per day transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely fentanyl 12 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Selegiline 6mg/24hours transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Selegiline 9mg/24hours transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Selegiline 12mg/24hours transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rivastigmine 4.6mg/24 hours transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rivastigmine 9.5mg/24 hours transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 0.06mg/day transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely estradiol 2.083 microgram/1 hour and norethisterone acetate 10.417 microgram/1 hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely estradiol 3.125 microgram/1 hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely estradiol 1.042 microgram/1 hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely estradiol 1.563 microgram/1 hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely estradiol 1.667 microgram/1 hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely rotigotine 83.333 microgram/1 hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely estradiol 2.083 microgram/1 hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely estradiol 2.083 microgram/1 hour and norethisterone acetate 7.083 microgram/1 hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely estradiol 3.333 microgram/1 hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely estradiol 4.167 microgram/1 hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely scopolamine 13.889 microgram/1 hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely fentanyl 25 microgram/1 hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely testosterone 104.167 microgram/1 hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely buprenorphine 35 microgram/1 hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely fentanyl 50 microgram/1 hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely buprenorphine 52.5 microgram/1 hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely buprenorphine 70 microgram/1 hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely fentanyl 75 microgram/1 hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely fentanyl 100 microgram/1 hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely granisetron 129.167 microgram/1 hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely rotigotine 166.667 microgram/1 hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely glyceryl trinitrate 208.333 microgram/1 hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely testosterone 208.333 microgram/1 hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely testosterone 250 microgram/1 hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely nicotine 291.667 microgram/1 hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely nicotine 312.5 microgram/1 hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely glyceryl trinitrate 416.667 microgram/1 hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely nicotine 583.333 microgram/1 hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely glyceryl trinitrate 625 microgram/1 hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely nicotine 625 microgram/1 hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely rotigotine 250 microgram/1 hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely nicotine 875 microgram/1 hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely nicotine 937.5 microgram/1 hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely estradiol 2.08 microgram/1 hour and norethisterone acetate 10.4 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely estradiol 1.04 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely estradiol 1.56 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely estradiol 1.88 microgram/1 hour and levonorgestrel 625 nanogram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely estradiol 2.5 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely estradiol 2.08 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely ethinylestradiol 1.46 microgram/1 hour and norelgestromin 6.25 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely estradiol 3.13 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely estradiol 4.17 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely selegiline 250 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely estradiol 2.08 microgram/1 hour and norethisterone acetate 5.83 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely estradiol 583 nanogram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely selegiline 500 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely oxybutynin 162 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely selegiline 375 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely nicotine 917 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely nicotine 458 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely rivastigmine 192 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely rivastigmine 396 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely rotigotine 125 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely rotigotine 41.667 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely buprenorphine 5 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely nicotine 1.563 milligram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely buprenorphine 15 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transiderm-Nitro 10 transdermal patches (DE Pharmaceuticals) 28 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transiderm-Nitro 5 transdermal patches (DE Pharmaceuticals) 28 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 8mg/24hours transdermal patches (Ethigen Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 50micrograms/hour transdermal patches (Pilsco Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 75micrograms/hour transdermal patches (Pilsco Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 12micrograms/hour transdermal patches (Pilsco Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 75micrograms/hour transdermal patches (Pilsco Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 8mg/24hours transdermal patches (Ethigen Ltd) 28 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 4mg/24hours transdermal patches (Ethigen Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Matrifen 25micrograms/hour transdermal patches (Pilsco Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 4mg/24hours transdermal patches (Ethigen Ltd) 28 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Matrifen 12micrograms/hour transdermal patches (Pilsco Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Matrifen 12micrograms/hour transdermal patches (Pilsco Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Evorel Conti patches (Pilsco Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Matrifen 25micrograms/hour transdermal patches (Pilsco Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 50micrograms/hour transdermal patches (Pilsco Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier

Page 1 of 21 Next End

This concept is not in any reference sets

Back to Start